TWELVE DRUGS ON THE WAY TO EUROPEAN APPROVAL - TREATMENTS FOR CANCER, HAEMOPHILIA AND MYASTHENIA MYASTHENIA AMONG OTHERS ON THE EMA LIST - Filenews 21/9 by Marilena Panayi
Twelve medicines were recommended for approval by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) at its meeting at the end of last week.
Among them are treatments for different forms of cancer, hemophilia A, generalized myasthenia gravis and short bowel syndrome, as well as a vaccine against rabies.
The list also includes two biosimilars and two generic drugs. A positive opinion is a recommendation for approval, not a marketing authorisation for which the European Commission is responsible.